ZJ43 is a potent NAAG peptidase inhibitor with an IC50 of 2.4 nM and a Ki of 0.8 nM; it effectively activates group II mGluRs and attenuates certain behavioral effects of PCP; it exhibits analgesic effects in models of neuropathy, inflammation, and pain.